Pregled bibliografske jedinice broj: 1222976
Influence of Non-pharmacological Treatment on Pain, Morning Stiffness, Fatigue, and Physical Function in Patients with Psoriatic Arthritis
Influence of Non-pharmacological Treatment on Pain, Morning Stiffness, Fatigue, and Physical Function in Patients with Psoriatic Arthritis // Acta dermatovenerologica Croatica, 28 (2020), 3; 148-153 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1222976 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Influence of Non-pharmacological Treatment on
Pain, Morning Stiffness,
Fatigue, and Physical Function in Patients with
Psoriatic Arthritis
(Influence of Non-pharmacological Treatment on
Pain, Morning Stiffness, Fatigue, and Physical
Function in Patients with Psoriatic Arthritis)
Autori
Špoljarić Carević S, Car J, Čota S, Delimar V, Perić P, Laktašić-Žerjavić
Izvornik
Acta dermatovenerologica Croatica (1330-027X) 28
(2020), 3;
148-153
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
psoriatic arthritis, rehabilitation, pain, physical functional performance, fatigue, naphtalanotherapy
Sažetak
Naphthalanotherapy (NT) is a therapeutic procedure that uses mineral oil obtained from petroleum. The aim of this study was to investigate the influence of the duration of NT combined with an individually adjusted rehabilitation program (IARP) on pain, morning stiffness (MS), fatigue, and physical function in patients with psoriatic arthritis (PsA). A total of 29 consecutive patients with PsA were divided into two groups. Group 1 (n=17) participated in a two-week and Group 2 (n=12) in a three-week intervention program. Pain (using the Visual Analogue Scale – VAS), fatigue (VAS and Functional Assessment of Chronic Illness Therapy- Fatigue – FACIT-F), duration of MS (minutes), and physical function (Health Assessment Questionnaire – HAQ) were assessed before and after therapy. Statistical analysis was performed using SPSS version 20, with P<0.05. There was a significant improvement in VAS-pain, VAS-fatigue, MS, HAQ, and FACIT-F before vs after therapy: Group 1:5.88±1.62 vs 3.94±1.25, P=0.001 ; 6.59±1.73 vs 4.35±1.73, P=0.001 ; 35.47±31.64 vs 23.71±29.30, P=0.001 ; 1.43±0.78 vs 1.23±0.74, P=0.001 ; 25.88±10.89 vs 30.71±10.65, P=0.009 ; Group 2: 6.17±1.27 vs 3.92±1.44, P=0.001 ; 6.50±1.93 vs 3.75±1.71, P=0.001 ; 38.42±32.00 vs 21.25±17.31, P=0.006 ; 1.47±0.79 vs 0.93±0.54, P=0.008 ; 25.00±9.87 vs 36.83±7.20, P=0.001, respectively. Regarding the length of the therapy, significant difference was reached only in FACIT-F (P=0.009). Two-week and three-week NT combined with IARP are equally efficient in reduction of pain and MS, as well as in improving physical function in patients with PsA. The three-week program showed an additional effect on reducing fatigue assessed by the FACIT-F score
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE